Dr. Abhishek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8266 Atlee Rd
Suite 225
Mechanicsville, VA 23116Phone+1 804-764-7220Fax+1 804-764-6212
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
Carilion Clinic-Virginia Tech Carilion School of MedicineResidency, Internal Medicine, 2004 - 2007
Delhi University College of Medical SciencesClass of 2000
University of Iowa Hospitals and ClinicsResidency, Internal Medicine
Certifications & Licensure
VA State Medical License 2004 - 2026
MO State Medical License 2009 - 2012
PA State Medical License 2008 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 17 citationsThe Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.Umut Disel, Russell Madison, Kumar Abhishek, Jon Chung, Sally E. Trabucco
The Oncologist. 2020-01-01 - 6 citationsAre there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positro...Nghi Nguyen, Kumar Abhishek, Samuel Nyon, Hussein Farghaly, Medhat Osman
Annals of Thoracic Medicine. 2016-01-01 - 4 citationsEpinastine: topical ophthalmic second generation antihistamine without significant systemic side effects.Shilpi Pradhan, Kumar Abhishek, Francis S. Mah
Expert Opinion on Drug Metabolism & Toxicology. 2009-08-18
Press Mentions
India Today Reporter Kumar Abhishek Gets Second Dose of Bharat Biotech's Covaxin as Part of Phase 3 TrialsJanuary 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
